Treatment algorithms

Table 1: Algorithm for treatment with TNF inhibitors of patients with treatment failure.

Measurable drug level
/ Negative for NAbs

Drug level below detection limit / Negative for NAbs

Drug level below detection limit / Positive for NAbs

• Compliance issues? Does the patient take the medication as directed?
• Does the patient need a higher drug dose or more frequent dosing interval?
• The patient’s disease is not driven by TNF levels. Change type of treatment.
• Was the sample collected at Cmin? NAbs are measured with optimal result at Cmin.

• Compliance issues? Does the patient take the medication as directed?
• Does the patient need a higher drug dose or more frequent dosing interval?
• Non-neutralizing ADA can both limit the bioavailability (with local administration of the drug) and increase the elimination of drug in circulation.

• Change TNF inhibitor because NAbs influence the activity of the currently used TNF inhibitor.

Inspiration from Bendtzen 2011, 2013, Garcês 2013, Vincent 2013.

 

Table 2: Algorithm for treatment with TNF inhibitors of patients that respond to treatment.

Measurable drug level /Negative for NAbs

Drug level below the detection limit / Positive for NAbs

• Everything is OK. Follow up with new tests at regular intervals.
• Should the drug dosage be adjusted?
• Is the patient is in remission and can treatment be discontinue?

• The patient is in remission and can formally discontinue treatment.

Inspiration from Bendtzen 2011, 2013, Garcês 2013, Vincent 2013.

Clinical studies

Product News

January 31, 2018
New test and other Request Forms changes for 2018 »

Changes in the Portfolio from January 2018.